Power Outages - Our Newtown Square office is experiencing a power outage due to severe weather. Please await further updates.
Carl Regillo, MD was interviewed by MD Magazine to discuss the clinical usage of the new anti-VEGF injection treatment, brolucizumab (Beovu), that has been approved by the FDA for the treatment of Wet Macular Degeneration.
Carl Regillo, MD was interviewed by MD Magazine to discuss the clinical usage of the new anti-VEGF injection treatment, brolucizumab (Beovu), that has been approved by the FDA for the treatment of Wet Macular Degeneration.